Study of Royal Jelly effect on serum levels of IL-4, TNF- α, TGF-B, and IFN-γ in multiple sclerosis patients in comparison with Omega-3; A double-blind, randomized, clinical trial. | Synapse
February 8, 2026
Study of Royal Jelly effect on serum levels of IL-4, TNF- α, TGF-B, and IFN-γ in multiple sclerosis patients in comparison with Omega-3; A double-blind, randomized, clinical trial.
Key Points
This research aims to investigate the effects of royal jelly and omega-3 on cytokine levels in multiple sclerosis patients.
Conducted as a double-blind, randomized clinical trial
Compared serum levels of IL-4, TNF-α, TGF-β, and IFN-γ
Included multiple sclerosis patients as the target population
Indications that both royal jelly and omega-3 may positively influence cytokine levels in MS patients
No specific quantitative data provided in the abstract
Abstract
According to the findings, it is hoped that using RJ and ω-3 could be helpful in MS patients.